Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
Jeffrey Neal Johnson

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer

[content-module:CompanyOverview|NASDAQ:PODD]

Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the S&P 500.

The medical device company, known for its innovative tubeless insulin pump system, saw its stock price climb by over 24% in the past five days. This jump in Insulet’s stock price has been driven by multiple catalyst’s including a recent earnings report that exceeded analyst predictions.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.